JPH01290614A - Sebum secretion promoter - Google Patents
Sebum secretion promoterInfo
- Publication number
- JPH01290614A JPH01290614A JP12036788A JP12036788A JPH01290614A JP H01290614 A JPH01290614 A JP H01290614A JP 12036788 A JP12036788 A JP 12036788A JP 12036788 A JP12036788 A JP 12036788A JP H01290614 A JPH01290614 A JP H01290614A
- Authority
- JP
- Japan
- Prior art keywords
- sebum
- extract
- propolis
- sebum secretion
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000002374 sebum Anatomy 0.000 title claims abstract description 31
- 230000028327 secretion Effects 0.000 title claims abstract description 23
- 241000241413 Propolis Species 0.000 claims abstract description 23
- 229940069949 propolis Drugs 0.000 claims abstract description 23
- 239000000284 extract Substances 0.000 claims abstract description 20
- 230000000694 effects Effects 0.000 abstract description 9
- 239000000203 mixture Substances 0.000 abstract description 8
- 239000002904 solvent Substances 0.000 abstract description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 6
- 210000001732 sebaceous gland Anatomy 0.000 abstract description 6
- 208000024891 symptom Diseases 0.000 abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract description 4
- 210000000056 organ Anatomy 0.000 abstract description 4
- 241000257303 Hymenoptera Species 0.000 abstract description 3
- 201000004681 Psoriasis Diseases 0.000 abstract description 2
- 238000004821 distillation Methods 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 239000011347 resin Substances 0.000 abstract description 2
- 229920005989 resin Polymers 0.000 abstract description 2
- 101100536354 Drosophila melanogaster tant gene Proteins 0.000 abstract 1
- 238000007598 dipping method Methods 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 239000011259 mixed solution Substances 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 239000012261 resinous substance Substances 0.000 abstract 1
- 238000007788 roughening Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- -1 aromatic alcohols Chemical class 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- LJINSKIHVMGTDJ-UHFFFAOYSA-N 2-(2,2-diaminoethylamino)acetic acid Chemical compound NC(N)CNCC(O)=O LJINSKIHVMGTDJ-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- PJJGZPJJTHBVMX-UHFFFAOYSA-N 5,7-Dihydroxyisoflavone Chemical compound C=1C(O)=CC(O)=C(C2=O)C=1OC=C2C1=CC=CC=C1 PJJGZPJJTHBVMX-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- ACEWLPOYLGNNHV-UHFFFAOYSA-N Ibuprofen piconol Chemical compound C1=CC(CC(C)C)=CC=C1C(C)C(=O)OCC1=CC=CC=N1 ACEWLPOYLGNNHV-UHFFFAOYSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- JDLSRXWHEBFHNC-UHFFFAOYSA-N Ufenamate Chemical compound CCCCOC(=O)C1=CC=CC=C1NC1=CC=CC(C(F)(F)F)=C1 JDLSRXWHEBFHNC-UHFFFAOYSA-N 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000009341 apiculture Methods 0.000 description 1
- 150000003934 aromatic aldehydes Chemical class 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 238000010227 cup method (microbiological evaluation) Methods 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 150000002208 flavanones Chemical class 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229950005954 ibuprofen piconol Drugs 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229960003464 mefenamic acid Drugs 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- SLYPOVJCSQHITR-UHFFFAOYSA-N tioxolone Chemical compound OC1=CC=C2SC(=O)OC2=C1 SLYPOVJCSQHITR-UHFFFAOYSA-N 0.000 description 1
- 229960003070 tioxolone Drugs 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 229950010121 ufenamate Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A61K8/988—Honey; Royal jelly, Propolis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は皮脂分泌促進剤に関する。更に詳しくは、皮脂
の分泌不足によっておこる肌荒れ、乾癖等の症状に対し
て温和な改善効果を示す皮脂分泌促進剤劣苓である。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a sebum secretion promoter. More specifically, it is a sebum secretion promoter that shows a mild improvement effect on symptoms such as rough skin and psoriasis caused by insufficient secretion of sebum.
[従来の技術]
プロポリス(Propolis:蜂ヤニ)とは、ミツバ
チによって植物から収集し、生産されるヤニ状物質であ
る。プロポリスは古くから伝承的民間薬として利用され
ており、近年東欧諸国を中心にその機能、作用が、解明
されつつある。抗菌作用、止血作用、搬痕化作用、抗炎
症作用、抗酸化作用、局所麻酔作用、腫瘍増殖抑制作用
等について多くの報告がある。プロポリスの成分はフラ
ボン類、フラバノン類、芳香族アルコール、芳香族アル
デヒド、クマリン等が主なもので、これらの組成、含有
量等はプロポリスの産地によって異なり、作用も差異が
あると言われている。[Prior Art] Propolis is a tar-like substance collected from plants and produced by bees. Propolis has been used as a traditional folk medicine since ancient times, and in recent years its functions and effects have been elucidated mainly in Eastern European countries. There are many reports on its antibacterial, hemostatic, scarring, anti-inflammatory, antioxidant, local anesthetic, and tumor growth inhibitory effects. The main components of propolis are flavones, flavanones, aromatic alcohols, aromatic aldehydes, coumarins, etc. The composition and content of these substances vary depending on where propolis is produced, and it is said that their effects also differ. .
一方、皮脂の分泌不足によって起きる肌荒れ、乾鮮等の
症状に対して皮脂線に特異的に作用して皮脂分泌を促進
し、かつ、皮脂腺以外の器官に対しては影響を及ぼさな
いような化合物は今日まで知られていない。On the other hand, compounds that specifically act on sebaceous glands to promote sebum secretion and do not affect organs other than the sebaceous glands are used to treat symptoms such as rough skin and dry skin caused by insufficient secretion of sebum. is unknown until today.
[発明が解決しようとする課題]
そこで本発明者らは、皮脂腺に対し特異的に作用して皮
脂分泌促進を示し、かつ皮脂腺以外の器官に影響しない
ような化合物を研究していたところ、プロポリスの抽出
物が、この目的を達成できることを見いだして、本発明
を完成した。[Problems to be Solved by the Invention] Therefore, the present inventors were researching a compound that acts specifically on sebaceous glands to promote sebum secretion and does not affect organs other than the sebaceous glands, and found that propolis The present invention was completed based on the discovery that an extract of the following can achieve this purpose.
[!i!題を解決するための手段]
すなわち本発明は、プロポリスの抽出物からなる皮脂分
泌促進剤である。[! i! Means for Solving the Problems] That is, the present invention is a sebum secretion promoter comprising an extract of propolis.
以下、本発明の構成について、詳述する。Hereinafter, the configuration of the present invention will be explained in detail.
本発明に用いられるプロポリス(propolis)は
、前述の通り、ミツバチによって植物から採取されるヤ
ニ状の物質であり、蜂ヤニとも呼ばれている。As mentioned above, propolis used in the present invention is a resin-like substance collected from plants by bees, and is also called bee resin.
−船釣には養蜂の際に巣箱の巣枠や隙間に多量に付着す
るのでこれをかきとって採集される。-When fishing by boat, a large amount of bee-keeping sticks to the frames and crevices of hives, so they are collected by scraping them off.
上記のプロポリスからの抽出液または抽出物は以下の様
にして製造される。プロポリスを水と親水性溶媒の混液
あるいは親水性溶媒に浸漬して抽出しく一般的にはプロ
ポリスの10重量倍程度の抽出液を用いる)、プロポリ
ス抽出液を得る。親水性溶媒としては、例えばメタノー
ル、エタノール等のアルコール及びアセトンなどが挙げ
られる。The above-mentioned extract or extract from propolis is produced as follows. Propolis is extracted by immersing it in a mixture of water and a hydrophilic solvent or in a hydrophilic solvent (generally, an extract having an amount of about 10 times the weight of propolis is used) to obtain a propolis extract. Examples of the hydrophilic solvent include alcohols such as methanol and ethanol, and acetone.
プロポリス抽出液から蒸留その他の方法で溶媒を留去す
ることにより、プロポリス抽出物を得る。A propolis extract is obtained by removing the solvent from the propolis extract by distillation or other methods.
皮脂分泌促進剤として、他の外用剤に配合するときの配
合量は抽出物(抽出溶媒を留去した残分)として全組成
中に概ね1%(重量%)をこえる量を配合する。配合量
の上限は特に限定するものではないが着色等の商品価値
や皮脂分泌促進効果の観点からプロポリスおよびその抽
出物の配合量は、乾燥残部として合計で3%〜20%程
度まで配合するのが好ましい。When incorporated into other external preparations as a sebum secretion promoter, the amount of the extract (residue after distilling off the extraction solvent) is generally greater than 1% (wt%) in the total composition. There is no particular upper limit to the amount of propolis and its extracts, but from the viewpoint of commercial value such as coloring and the effect of promoting sebum secretion, the amount of propolis and its extracts should be blended at a total of 3% to 20% as dry residue. is preferred.
本発明には、プロポリス抽出物のほかにイオウ、ヒノキ
チオール、トリクロサン、トリクロロカルバニリド、ク
ロルヘキシジン塩酸塩、クロルヘキシジングルコン酸塩
、ハロカルパン、クロロフェネシン、塩化ベンゼトニウ
ム、塩化ベンザルコニウム、塩化リゾチーム、塩酸アル
キルジアミノエチルグリシン、イソプロピルメチルフェ
ノール、安息香酸、感光素201号、チモール、ヘキサ
クロロフェン、ベルベリン、チオキソロンなどの抗菌剤
、またビタミンA%C,B2、B6、B1゜、E1ビオ
チン、ニコチン酸等のビタミン剤やサリチル酸、レゾル
シン等の角質剥離剤、クリチルレチン酸、クリチルリチ
ン酸、アラントイン、イプシロンアミノカプロン酸、フ
ルフェナム酸ブチル、アズレン、カンファー、塩化亜鉛
、亜鉛華、メントール、インドメタシン、イブプロフェ
ンピコノール、メフェナム酸ならびにそれらの誘導体等
の抗炎症剤、γ−オリザノール、さらに亜鉛およびその
化金物、乳酸および性状によっても異なるが、油分、界
面活性剤、水、エタノール、保湿剤、増粘剤、香料、色
素等を本発明の効果を損なわない範囲で適宜配合するこ
とができる。In addition to propolis extract, the present invention contains sulfur, hinokitiol, triclosan, trichlorocarbanilide, chlorhexidine hydrochloride, chlorhexidine gluconate, halocarpan, chlorophenesine, benzethonium chloride, benzalkonium chloride, lysozyme chloride, alkyl hydrochloride. Antibacterial agents such as diaminoethylglycine, isopropylmethylphenol, benzoic acid, Photosensor No. 201, thymol, hexachlorophene, berberine, and thioxolone, and vitamins such as vitamin A% C, B2, B6, B1°, E1 biotin, and nicotinic acid. Exfoliating agents such as salicylic acid and resorcinol, clycyrrhetinic acid, clycyrrhizic acid, allantoin, epsilon aminocaproic acid, butyl flufenamate, azulene, camphor, zinc chloride, zinc white, menthol, indomethacin, ibuprofen piconol, mefenamic acid, and their Anti-inflammatory agents such as derivatives, γ-oryzanol, zinc and its metal compounds, lactic acid, and although it varies depending on the properties, oils, surfactants, water, ethanol, humectants, thickeners, fragrances, pigments, etc. can be used in the present invention. It can be blended as appropriate within a range that does not impair the effects of.
[実施例] 次に実施例により本発明をさらに詳細に説明する。[Example] Next, the present invention will be explained in more detail with reference to Examples.
本発明の皮脂分泌促進剤を、ローションの中に配合して
臨床例により効果をしらべた。The sebum secretion enhancer of the present invention was incorporated into a lotion and its effectiveness was investigated using clinical examples.
(使用薬剤 )
下記処方、製造法で得たローションタイプの皮脂分泌促
進剤を使用した。(Medicine used) A lotion-type sebum secretion stimulant obtained by the following formulation and manufacturing method was used.
1)プロポリス抽出物 5.0g2
) P OE (60モル)硬化ヒマシ油 2
.0g3)グリセリン 9.0
g4)ジプロピレングリコール 9.0g5
)1.3−ブチレングリコール 5.0g6)ポ
リエチレングリコール1500 5.0g7)セ
チルイソオクタネート 10.0g8)スク
ワラン 5.0g9)メチル
パラベン 1.0 glo)カル
ボキシビニルポリマー 0.3g11)へキサ
メタリン酸ソーダ 0.08g12)イオン
交換水 11.0g13)水酸化カ
リウム 0.12 g14)イオン
交換水 37.5g1)2)3)4
)5)6)を60℃で加熱溶解する。これに7)8)9
)を同じ<60℃に加熱溶解したものを添加混合し、ホ
モミキサーで処理をしてゲルを作る。次にこのゲルに1
0) 11)を、12)に溶解せしめたものを徐添加し
ホモミキサーで分散した後、13)を14)に溶解した
ものを添加混合し、ホモミキサーで乳化してローション
の中に皮脂分泌促進剤を配合した。1) Propolis extract 5.0g2
) P OE (60 mol) Hydrogenated castor oil 2
.. 0g3) Glycerin 9.0
g4) Dipropylene glycol 9.0g5
) 1.3-Butylene glycol 5.0g6) Polyethylene glycol 1500 5.0g7) Cetyl isooctanaate 10.0g8) Squalane 5.0g9) Methylparaben 1.0 glo) Carboxyvinyl polymer 0.3g11) Sodium hexametaphosphate 0. 08g12) Ion exchange water 11.0g13) Potassium hydroxide 0.12 g14) Ion exchange water 37.5g1)2)3)4
) 5) Dissolve 6) by heating at 60°C. To this 7) 8) 9
) was added and mixed by heating to <60°C, and processed with a homomixer to form a gel. Next, add 1 to this gel.
0) Gradually add 11) dissolved in 12) and disperse with a homomixer, then add and mix 13) dissolved in 14), emulsify with a homomixer, and release sebum into the lotion. Contains accelerator.
(使用対象および観察期間)
30〜40歳までの明かに皮脂分泌不足の肌荒れの患者
20名に4週間使用させた。(Targets for Use and Observation Period) The product was used for 4 weeks on 20 patients between the ages of 30 and 40 with rough skin due to obvious lack of sebum secretion.
(使用方法)
顔面に前記したローションタイプの皮脂分泌促通則を1
日に3回以上塗布せしめた。(How to use) Apply the above-mentioned lotion-type sebum secretion promotion rules on the face.
It was applied at least 3 times a day.
(皮脂の測定)
使用前と4週間使用後の総皮脂量をガラスカップ法で皮
脂を採取して重量法[Ohokawa、H,、et a
l、。(Measurement of sebum) The total amount of sebum before use and after 4 weeks of use was measured by collecting sebum using the glass cup method and using the gravimetric method [Ohokawa, H., et al.
l.
Anal、Biochem、、95.351358(1
979)]にて測定した。Anal, Biochem, 95.351358 (1
979)].
皮脂量は以下の式のごとく相対比で表した。The amount of sebum was expressed as a relative ratio as shown in the following formula.
(以下余白)
(結果)
症例番号 年令 性 皮脂増加率
1 30 女 12
2 32 男 10
3 40 女 8
4 36 男 9
5 35 女 5
6 36 女 11
7 38 女 9
8 36 女 13
9 31 女 8
10 33 女 6
11 30 女 1112 3
0 男 1513 32 女
5
症例番号 年令 性 皮膚増加率
14 36 男 1115 3
3 男 1216 32 男
1017 30 男 518
35 女 3
19 36 女 320 3
6 女 2
男7名、女13名計20名の臨床テスト結果、平均皮脂
増加率は8.4%であり、本発明の皮脂分泌促進剤の効
果が立証された。(Left below) (Results) Case number Age Gender Sebum increase rate 1 30 Female 12 2 32 Male 10 3 40 Female 8 4 36 Male 9 5 35 Female 5 6 36 Female 11 7 38 Female 9 8 36 Female 13 9 31 Female 8 10 33 Female 6 11 30 Female 1112 3
0 Male 1513 32 Female
5 Case number Age Sex Skin increase rate 14 36 Male 1115 3
3 men 1216 32 men
1017 30 Male 518
35 Female 3 19 36 Female 320 3
6 Female 2 The results of a clinical test conducted on 20 people (7 males and 13 females) showed that the average sebum increase rate was 8.4%, proving the effectiveness of the sebum secretion promoter of the present invention.
次に軟膏の中に本発明品を配合した配合例を示す。Next, a formulation example in which the product of the present invention is blended into an ointment will be shown.
1)固体パラフィン 10・0g
2)ピースワックス 10・0g
3)スクワラン 10・0g
4)プロポリス抽出物 4・0g
5)レゾルシン 0・1g6
)香料 適量7)ワセ
リン 65.9g上記成
分を混合し、混合物を80℃に加熱溶解した後、攪拌冷
却を行い、軟膏を得た。1) Solid paraffin 10.0g
2) Peace wax 10.0g
3) Squalane 10.0g
4) Propolis extract 4.0g
5) Resorcinol 0.1g6
) Perfume Appropriate amount 7) Vaseline 65.9g The above ingredients were mixed, the mixture was heated and dissolved at 80°C, and then cooled with stirring to obtain an ointment.
[発明の効果]
本発明の皮脂分泌促進剤は、非常に良好な皮脂分泌促進
効果を示す。また非常に良く皮膚に浸透し、しかもその
活性は特異的に皮脂腺にのみ向けられ、それら以外の器
官には全く刺激を与えないので、特に皮脂分泌不足の症
状の改善に適する。[Effects of the Invention] The sebum secretion promoting agent of the present invention exhibits a very good sebum secretion promoting effect. In addition, it penetrates the skin very well, and its activity is specifically directed only to the sebaceous glands and does not irritate any other organs, making it particularly suitable for improving symptoms of insufficient sebum secretion.
特許出願人 株式会社 資生堂Patent applicant: Shiseido Co., Ltd.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12036788A JPH01290614A (en) | 1988-05-17 | 1988-05-17 | Sebum secretion promoter |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12036788A JPH01290614A (en) | 1988-05-17 | 1988-05-17 | Sebum secretion promoter |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01290614A true JPH01290614A (en) | 1989-11-22 |
Family
ID=14784447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP12036788A Pending JPH01290614A (en) | 1988-05-17 | 1988-05-17 | Sebum secretion promoter |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01290614A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015107703A1 (en) * | 2014-01-15 | 2015-07-23 | 相互 秋田 | Chemical composition |
JP2021065114A (en) * | 2019-10-18 | 2021-04-30 | 株式会社山田養蜂場本社 | Skin barrier function improver |
-
1988
- 1988-05-17 JP JP12036788A patent/JPH01290614A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015107703A1 (en) * | 2014-01-15 | 2015-07-23 | 相互 秋田 | Chemical composition |
JP2021065114A (en) * | 2019-10-18 | 2021-04-30 | 株式会社山田養蜂場本社 | Skin barrier function improver |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002309036B2 (en) | Preparation for hair and/or scalp | |
JPH03190809A (en) | Skin external preparation | |
JPH03220129A (en) | Sebum suppressant | |
JP3223404B2 (en) | Hair restorer | |
JPS63192705A (en) | External agent for skin | |
JP5916799B2 (en) | Extract from sturgeon eggs | |
JP5561912B2 (en) | Extract from sturgeon eggs | |
JP2878353B2 (en) | External preparation for skin | |
JPS63179812A (en) | External preparation for skin | |
JPS6360910A (en) | Skin drug for external use | |
JPH11269034A (en) | Skin prepafation for external use for improving acne | |
JP2000191493A (en) | Medicated cosmetic | |
JPH01290614A (en) | Sebum secretion promoter | |
JPH09291013A (en) | Skin cosmetic material | |
JPS6322510A (en) | External preparation for skin | |
JPS6360909A (en) | Skin drug for external use | |
JPH11302147A (en) | Cosmetic | |
JPS6360935A (en) | Sebum suppressive agent | |
JPS6322506A (en) | External preparation for skin | |
RU2139035C1 (en) | Dentifrice water | |
JPH0517202B2 (en) | ||
JPS6360908A (en) | Skin drug for external use | |
JPH05339140A (en) | Skin cosmetic | |
US20210145917A1 (en) | Composition having effect of alleviating bromhidrosis | |
JPH043363B2 (en) |